Skip to content Skip to sidebar Skip to footer
Orphan drug designation
Orphan Drug Designation: What is it and why is it a big deal for biotech stocks?
While most small cap health stocks dream of commercialisation, healthcare companies at an early stage get excited about achieving Orphan Drug Designation. Achieving this won't be as meaningful to the bottom line as a stock receiving regulatory approval, but it is a big step nonetheless. If and when commercialisation is achieved, this will have been a…
Meta Platforms
Meta Platforms (NDQ:META): With 3bn+ users, is it the dark horse in the rapid AI race? And can we trust it after the VR and metaverse flops?
Let's look at Meta Platforms (NDQ:META), a company that changed its name in 2021 thinking that the metaverse would be as big as the Internet. Well, there's some way to go there. Same with virtual reality.     But if there's another 3bn+ social network, let's hear about it. Facebook may have 'lost its gloss' post the Cambridge…
Botanix Pharmaceuticals
Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?
Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this magnitude would suggest the FDA knocked back its drug or that it failed a clinical trial. With Botanix having commercialised its treatment, neither was the case, so it'd have to be a pretty bad sales update.…
trade international stocks
So you want to trade international stocks? Here’s 4 things to consider
Modern technology allows Australian investors to trade international stocks just like local shares. But going abroad might be daunting for investors who have never done it before, even those who are experienced with Australian equities. It is not impossible, though, and this article will outline how to set up your trading account to trade international shares.   How to…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here